APA (7th ed.) Citation

MJ, F., & JN, H. (2015). Fatal Stevens-Johnson syndrome/toxic epidermal necrolysis induced by allopurinol-rituximab-bendamustine therapy. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 21(5), 388. https://doi.org/10.1177/1078155214533368

Chicago Style (17th ed.) Citation

MJ, Fallon, and Heck JN. "Fatal Stevens-Johnson Syndrome/toxic Epidermal Necrolysis Induced by Allopurinol-rituximab-bendamustine Therapy." Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners 21, no. 5 (2015): 388. https://doi.org/10.1177/1078155214533368.

MLA (9th ed.) Citation

MJ, Fallon, and Heck JN. "Fatal Stevens-Johnson Syndrome/toxic Epidermal Necrolysis Induced by Allopurinol-rituximab-bendamustine Therapy." Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners, vol. 21, no. 5, 2015, p. 388, https://doi.org/10.1177/1078155214533368.